Regal Assets Analytics

Call Us: (800) 891-1526

M - F 8AM to 4PM ET

Bill Langbein

New Magenta Catalyst MGTA-145 After Company Drops MGTA-456 Phase II Trial

By |2020-06-27T15:59:19-04:00June 26th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment, SanaCurrents Updates|Tags: |

Shares of Magenta Therapeutics (NASDAQ: MGTA) declined 22% on June [...]

Molecular Templates (MTEM) Probability Sentiment

By |2020-06-17T13:43:02-04:00June 13th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

Molecular Templates, Inc. (NASDAQ:MTEM) Probability Sentiment [...]

Selecta Licenses Away Promising Gout Drug; SanaCurrents Suspending Coverage

By |2020-06-12T14:04:15-04:00June 12th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents Updates|Tags: , , |

After the market closed on June 11, Selecta Biosciences, Inc. [...]